Long-term tralokinumab therapy in moderate to severe atopic dermatitis

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
AKTUELLE DERMATOLOGIE | 2023年 / 49卷 / 03期
关键词：
D O I：
10.1055/a-1974-5392
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [41] Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
    Blauvelt, Andrew
    Langley, Richard G.
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Beissert, Stefan
    Wollenberg, Andreas
    Herranz, Pedro
    Pink, Andrew E.
    Peris, Ketty
    Fangel, Stine
    Gjerum, Le
    Corriveau, Joshua
    Saeki, Hidehisa
    Warren, Richard B.
    Simpson, Eric
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 815 - 824
  • [42] Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study
    Vedie, Anne-Laure
    Ezzedine, Khaled
    Amazan, Emmanuelle
    Boralevi, Franck
    Milpied, Brigitte
    Taieb, Alain
    Seneschal, Julien
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (06) : 802 - 806
  • [43] LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH DUPILUMAB UP TO 4 YEARS
    Blauvelt, A.
    Eichenfield, L.
    Sierka, D.
    Chen, Z.
    Khokhar, F.
    Marco, A. Rodriguez
    Shabbir, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S19 - S19
  • [44] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
    Deleuran, M.
    Thaci, D.
    Beck, L.
    Forman, S.
    Soong, W.
    Hussain, I.
    Bissonnette, R.
    Bouaziz, J.
    Gelfand, J.
    Lawrence, S.
    Chen, Z.
    Akinlade, B.
    Gadkari, A.
    Eckert, L.
    Graham, N.
    Ardeleanu, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
  • [45] Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
    Ayen-Rodriguez, Angela
    Pereyra-Rodriguez, Jose-Juan
    Navarro-Trivino, Francisco J.
    Alcantara-Luna, Sara
    Dominguez-Cruz, Javier
    Galan-Gutierrez, Manuel
    Vilar-Palomo, Samuel
    Armario-Hita, Jose Carlos
    Ruiz-Villaverde, Ricardo
    LIFE-BASEL, 2022, 12 (08):
  • [46] Dupilumab provides long-term efficacy over 2.5 years in adults with moderate-to-severe atopic dermatitis
    Cork, Michael
    Beck, Lisa
    Bissonnette, Robert
    Wollenberg, Andreas
    Simpson, Eric
    Praestgaard, Amy
    Aamodt, Kimberly
    Rossi, Ana
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 69 - 69
  • [47] Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
    Kabashima, Kenji
    Furue, Masutaka
    Hanifin, Jon M.
    Pulka, Grazyna
    Wollenberg, Andreas
    Galus, Ryszard
    Etoh, Takafumi
    Mihara, Ryosuke
    Nakano, Miwa
    Ruzicka, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (04) : 1121 - +
  • [48] Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil
    Benez, A
    Fierlbeck, G
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (03) : 638 - 639
  • [49] Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
    BerthJones, J
    GrahamBrown, BAC
    Marks, B
    Camp, RDR
    English, JSC
    Freeman, K
    Holden, CA
    Rogers, SCF
    Oliwiecki, S
    Friedmann, PS
    LewisJones, MS
    Archer, CB
    Adriaans, B
    Douglas, WS
    Allen, BR
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) : 76 - 81
  • [50] Long-term use of a 4% sodium cromoglicate cutaneous emulsion in the treatment of moderate to severe atopic dermatitis in children
    Edwards, Alan Martin
    Bibawy, Dalia
    Matthews, Sharon
    Tongue, Nicky
    Arshad, Syed Hasan
    Carlsen, Karin Lodrup
    Oymar, Knut
    Pollock, Ian
    Clifford, Rollo
    Thomas, Anne
    Gamanya, Rufaro
    Vyas, Jui
    Stevens, Michael T.
    Carlsen, Kai-Hakon
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (06) : 541 - 547
12345